InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Sunday, 02/23/2020 4:29:46 AM

Sunday, February 23, 2020 4:29:46 AM

Post# of 807
AXO-Lenti-PD delivers a 22-point (44%) improvement from baseline in the second dose cohort at 6 months

$65 million offering is expected to close on February 24, 2020


HTTps://synthace.com/lp-oxb-webinar-feb20
@markusgershater
Biologist who aspires to engineer. CSO & cofounder
@synthace

I've just had a sneak preview of what Tom Evans and André Raposo from
@OxfordBiomedica
are going to present at next week's webinar. Truly blown away by the science they're doing with Antha.